Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs

At the beginning of 2011, the early benefit assessment of new drugs was introduced in Germany with the Act on the Reform of the Market for Medicinal Products (AMNOG). The Federal Joint Committee (G‐BA) generally commissions the Institute for Quality and Efficiency in Health Care (IQWiG) with this ty...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biom J
Main Authors: Skipka, Guido, Wieseler, Beate, Kaiser, Thomas, Thomas, Stefanie, Bender, Ralf, Windeler, Jürgen, Lange, Stefan
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Research Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034755/
https://ncbi.nlm.nih.gov/pubmed/26134089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bimj.201300274
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki